Marvell Technology Stock in Focus Following May 27 Catalyst Recommendation Trump Seeks Supreme Court Intervention to Halt TikTok Ban Perpetua Resources Secures 29 Billion Loan from US ExportImport Bank for Idaho Critical Minerals Project Spotify CEO Defends AI Music Integration Calls Remix Tool a Better Alternative to Unlicensed Slop Singapore April Inflation Misses Expectations at 18 Growth Forecast Revised Upward Gold Royalty Corp GROY Evaluating the Potential of a LowPriced Gold Stock REXR Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment NTRA Q1 2026 Earnings EPS Misses Estimates as Revenue Unreported Stock Slightly Down CMSA Q1 2026 Earnings EPS Surpasses Estimates amid Solid Operational Performance InspireMD NSPR Q1 2026 Earnings EPS Beat Despite Net Loss Shares Dip 29 Johnson Controls JCI Q1 2026 Earnings EPS Beats Estimates by Over 5 Amid Mixed Market Reaction Select Water Solutions WTTR Q1 2026 Earnings Strong EPS Beat Masks Mixed Sentiment Shares Dip Despite Profit Surprise Mineralys Therapeutics MLYS Edges Lower as Tight Trading Range Persists Central Puerto CEPU Springs Over 6 as Bullish Momentum Builds Minerva Neurosciences NERV Edges Lower as Stock Tests Key Support Zone Euro Tech Holdings CLWT Stability at 122 as Support and Resistance Boundaries Tighten BrightSpire Capital BRSP Edges Higher as Shares Hold Above Key Support SP 500 Edges Higher as Tech Surge Offsets Energy and Defensive Weakness American Consumer Pessimism Persists When Will Economic Sentiment Recover UK Government Borrowing Exceeds Forecasts in April as Inflation Raises Benefits Costs Spanish Brewer Hijos de Rivera Establishes Italian Subsidiary to Bolster European Presence Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience Stock Market Rally Gains Momentum as Earnings Season Heats Up Iran Deal News Looms CapitaLand Unveils 14 Billion Geneo Life Sciences Hub in Science Park Redevelopment Polaris Inc PII Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment After Challenging Quarter Mineralys Therapeutics MLYS Edges Lower as Tight Trading Range Persists